Concord Medical Services Holdings Limited ADS (Each represents three ordinary shares) (CCM) News
Filter CCM News Items
CCM News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest CCM News From Around the Web
Below are the latest news stories about CONCORD MEDICAL SERVICES HOLDINGS LTD that investors may wish to consider to help them evaluate CCM as an investment opportunity.
Concord Medical Schedules 2023 Annual Meeting of ShareholdersConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2023 annual general meeting of shareholders (the "Meeting") on December 26, 2023, at 10:00 a.m. (Beijing Time). The meeting will be held |
Concord Medical Reports Financial Results for the First Half of 2023Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023[1]. |
Concord Medical Services Holdings Limited (NYSE:CCM) Could Be Riskier Than It LooksWith a median price-to-sales (or "P/S") ratio of close to 1.3x in the Healthcare industry in the United States, you... |
Concord Medical Services Holdings (NYSE:CCM) shareholders are up 18% this past week, but still in the red over the last five yearsThis week we saw the Concord Medical Services Holdings Limited ( NYSE:CCM ) share price climb by 18%. But don't envy... |
Concord Medical Services Holdings Full Year 2022 Earnings: CN¥5.61 loss per share (vs CN¥18.79 loss in FY 2021)Concord Medical Services Holdings ( NYSE:CCM ) Full Year 2022 Results Key Financial Results Revenue: CN¥472.1m (down... |
Concord Medical Files 2022 Annual Report on Form 20-FConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 (the "Annual Report") with the U.S. Securities and Exchange Commissio |